FDA Must Act Quickly On Ranbaxy Lipitor ANDA: Mylan
Mylan Pharmaceuticals Inc. asked a Washington federal judge on Thursday not to toss its suit seeking to compel the U.S. Food and Drug Administration to remove the exclusivity provision from Ranbaxy...To view the full article, register now.
Already a subscriber? Click here to view full article